Wockhardt Profile
Key Indicators
- Authorised Capital ₹ 1,125.00 Cr
- Paid Up Capital ₹ 81.24 Cr
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,689.48 Cr
- Satisfied Charges ₹ 9,628.84 Cr
- Revenue Growth -19.22%
- Profit Growth -232.86%
- Ebitda -68.47%
- Net Worth -20.75%
- Total Assets -18.39%
About Wockhardt
Wockhardt Limited (WL) is a leading Public Limited Indian Non-Government Company incorporated in India on 08 July 1999 and has a history of 25 years and seven months. Its registered office is in Aurangabad, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532300 and on the National Stock Exchange(NSE) under WOCKPHARMA.
The Corporate was formerly known as Wockhardt Pharmaceuticals Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1,125.00 Cr and a paid-up capital of Rs 81.24 Cr.
The company currently has active open charges totaling ₹1,689.48 Cr. The company has closed loans amounting to ₹9,628.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Wockhardt Limited India are Deepak Madnani as CFO and Rashmi Mamtura as Company Secretary. Habil Khorakiwala, Murtaza Khorakiwala, Zahabiya Khorakiwala, and Five other members serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24230MH1999PLC120720
- Company No.
120720
- Stock Symbol
BSE : 532300 NSE : WOCKPHARMA
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1999
- Date of AGM
28 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Wockhardt Limited offer?
Wockhardt Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Healthcare Products & Aids, Health Drinks, Form Fill & Seal Machines, Pharmaceutical Packaging Machines, Business Planning and Management, Business Consultant, Project Management, Medical Refrigerator Systems.
Who are the key members and board of directors at Wockhardt?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murtaza Khorakiwala  | Managing Director | 31-Mar-2009 | Current |
| Deepak Madnani | CFO | 07-Jun-2022 | Current |
| Rashmi Mamtura | Company Secretary | 19-Aug-2023 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Huzaifa Khorakiwala | Whole-Time Director | 31-Mar-2009 | Current |
| Akhilesh Gupta | Director | 29-Aug-2020 | Current |
| Habil Khorakiwala | Whole-Time Director | 08-Jul-1999 | Current |
| Zahabiya Khorakiwala | Director | 30-Oct-2017 | Current |
| Vinesh Jairath | Director | 10-Nov-2016 | Current |
| Amelia Fernandes | Director | 18-Jul-2023 | Current |
Financial Performance of Wockhardt.
Wockhardt Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.22% decrease. The company also saw a substantial fall in profitability, with a 232.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wockhardt?
In 2023, Wockhardt had a promoter holding of 59.31% and a public holding of 40.69%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kirloskar Oil Engines LimitedVinesh Jairath is a mutual person
Sahyadri Hospitals Private LimitedVinesh Jairath is a mutual person
Wockhardt Hospitals LimitedHabil Khorakiwala, Murtaza Khorakiwala and 2 more are mutual person
The Bombay Dyeing And Manufacturing Company LimitedVinesh Jairath is a mutual person
Wockhardt Bionova LimitedHabil Khorakiwala, Murtaza Khorakiwala and 1 more are mutual person
- Wockhardt Regenerative Private Limited
Zahabiya Khorakiwala is a mutual person
Charges (Loans)
₹1,689.48 Cr
₹9,628.84 Cr
Charges Breakdown by Lending Institutions
- Sbicap Trustee Company Limited : 1125.05 Cr
- State Bank Of India : 476.43 Cr
- Others : 88.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2023 | Others | ₹75.00 Cr | Open |
| 29 Jul 2021 | Others | ₹13.00 Cr | Open |
| 27 Jan 2016 | Sbicap Trustee Company Limited | ₹1,125.05 Cr | Open |
| 09 Dec 2002 | State Bank Of India | ₹362.50 Cr | Open |
| 29 Dec 2000 | State Bank Of India | ₹113.93 Cr | Open |
How Many Employees Work at Wockhardt?
Wockhardt has a workforce of 2065 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wockhardt, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockhardt's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
